We have found that when copper, zinc or cobalt is bound to a suitable ligand, the appropriate complex exhibited a significant anti-HSV effect (Varadinova et al., 1993; 1996) . Recently published data by Sagripanti et al. (1997) also show that the inhibition of HSV by copper was enhanced by reducing agents and that mechanism of the inactivation is similar as for copper-mediated DNA damage (Aruoma, et al. 1991; Dizdaroglu, et al., 1991; Toyokuni and Sagripanti, 1994) . Therefore it was interesting to study the efect of Cu (ll) 
Introduction Acyclovir (ACV), the acyclic analogue of deoxyguanosine (9-(2-hydroxyethoxymethyl)guanine), is known as a specific and selective inhibitor of the replication of herpes viruses (Elion et al., 1977) . ACV has been effectively used over a decade in the treatment of patients with herpes simplex and herpes zoster diseases (Tilson et al., 1993) . Entering the infected cells, ACV is rapidly phosphorylated to ACV-monophosphate (ACV-MP) by the herpes virus-induced thymidine kinase (TK) (Elion et al., 1977 ) and subsequently to ACV-diphosphate (ACV-DP) and ACV-triphosphate (ACV-TP) by host-cell kinases (Elion et al., 1977; Fyfe et al., 1978) . The ACV-TP functions as a specific substrate for viral DNA polymerase (Elion et al., 1977; Schaeffer et al., 1978) thus preventing both the formation of the DNA replication complex and the elongation of the DNA chain (Furman et al., 1984, Reardon and Spector, 1989; Elion, 1993) . However, the multiple use of ACV, especially in suboptimal doses, leads to formation or selection of ACV-resistant viral mutants, a problem that is increasingly common (Chatis and Grumpacker, 1992) . This fact has encouraged the efforts to develop new drugs using, in particular, complexes of essential metals like copper, zinc and cobalt with different ligands.
As some of the complexes tested significantly inhibited HSV growth (Varadinova et 
